Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
03/15/1995 | EP0643136A1 Bacterion of Streptococcus thermophilus |
03/15/1995 | EP0643135A1 Process for producing l-threonine by fermentation |
03/15/1995 | EP0643134A1 Nucleic acid sequences and plasmids comprising at least one mechanism of phage resistance, bacteria comprising said sequences and their utilisation |
03/15/1995 | EP0643133A2 Recombinant D-hydantoinase, process for its preparation and its use |
03/15/1995 | EP0643132A1 $g(a)-1,3-FUCOSYLTRANSFERASE |
03/15/1995 | EP0643077A1 Monoclonal antibody against B70 molecule |
03/15/1995 | EP0643076A1 Novel peptide having receptor activity and dna coding for said peptide |
03/15/1995 | EP0643075A1 Novel peptide having elastase inhibitor activity and process for producing the same |
03/15/1995 | EP0642761A1 Method of quantitative determination of bone salt with ct equipment |
03/15/1995 | EP0642592A1 Ligase chain reaction starting with rna sequences |
03/15/1995 | EP0642591A1 Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
03/15/1995 | EP0642589A1 Method and reagent for inhibiting viral replication |
03/15/1995 | EP0642585A1 Activation of oligomerizing receptors by using fused receptor ligands |
03/15/1995 | EP0642584A1 Nucleic acid corresponding to a gene of chromosome 22 involved in recurrent chromosomal translocations associated with the development of cancerous tumors |
03/15/1995 | EP0642582A1 Hybrid siv/hiv-1 viral vectors and monkey model for aids |
03/15/1995 | EP0642581A1 Clostridium perfringens vaccines |
03/15/1995 | EP0642580A1 Hepatocyte growth factor variants |
03/15/1995 | EP0642579A1 Improved methods for the preparation of endotoxin-binding proteins |
03/15/1995 | EP0642577A1 Antibodies with specificity for multiple adhesion molecules |
03/15/1995 | EP0642524A1 Systemin |
03/15/1995 | EP0642356A1 Antibodies to p-selectin and their uses |
03/15/1995 | EP0642355A1 Combined vaccines comprising hepatitis b surface antigen and other antigens |
03/15/1995 | EP0642350A1 Method for modifying, diagnosing, and screening for igf-i sensitive cell barrier properties |
03/15/1995 | EP0642305A1 NOVEL BACILLUS THURINGIENSIS ISOLATE DENOTED B.t.PS158C2, ACTIVE AGAINST LEPIDOPTERAN PESTS, AND GENES ENCODING LEPIDOPTERAN-ACTIVE TOXINS |
03/15/1995 | EP0593631A4 Interstitial deletion in chromosomal dna. |
03/15/1995 | EP0309565B1 Subtilisin analogs |
03/14/1995 | USRE34875 Method of selecting recombinant DNA-containing streptomyces |
03/14/1995 | US5397712 In a living person, imunoassay using cerebrospinal fluid and a monoclonal antibody from a hybridoma ATCC HB11079 |
03/14/1995 | US5397705 Multiply mutated subtilisins |
03/14/1995 | US5397703 Method for generation of antibodies to cell surface molecules |
03/14/1995 | US5397697 Identification of genomic mutants for gene expression |
03/14/1995 | US5397694 For treatment of periodontal disease |
03/14/1995 | US5397591 Infant formula and baby food containing docosahexaenoic acid obtained from dinoflagellates |
03/14/1995 | CA2131760A1 Nucleic acid-binding oligomers possessing c-branching for therapy and diagnostics |
03/14/1995 | CA2106015A1 Ribozymes having 2'-0 substituted nucleotides in the flanking sequences |
03/09/1995 | WO1995006764A2 Oligonucleotides with rna cleavage activity |
03/09/1995 | WO1995006756A2 OLIGONUCLEOTIDES AND METHODS FOR THE DETECTION OF $i(CHLAMYDIA TRACHOMATIS) |
03/09/1995 | WO1995006755A1 Nucleic acid probes to mycobacterium avium complex |
03/09/1995 | WO1995006754A1 Methods for screening antiestrogen compounds |
03/09/1995 | WO1995006749A1 OLIGONUCLEOTIDES AND METHODS FOR THE DETECTION OF $i(NEISSERIA GONORRHOEAE) |
03/09/1995 | WO1995006748A1 Monoclonal antibody that induces apoptosis |
03/09/1995 | WO1995006747A1 Monoclonal antibody that recognizes interstitial cell surface antigen |
03/09/1995 | WO1995006745A1 Vector for gene therapy of the liver |
03/09/1995 | WO1995006744A2 Methods of suppressing immune response by gene therapy |
03/09/1995 | WO1995006743A2 Methods and compositions for the large scale production of recombinant adeno-associated virus |
03/09/1995 | WO1995006742A1 Enhanced expression in plants using non-translated leader sequences |
03/09/1995 | WO1995006741A1 Method of production of transgenic plants wholly transformed into to generation, from meristems |
03/09/1995 | WO1995006740A2 Medium chain-specific thioesterases |
03/09/1995 | WO1995006739A1 Multiple integrative vectors and yarrowia lipolytica transformants |
03/09/1995 | WO1995006736A1 BACTERIOCINS FROM $i(STREPTOCOCCUS THERMOPHILUS) |
03/09/1995 | WO1995006735A2 Nucleotide sequences for novel protein tyrosine phosphatases |
03/09/1995 | WO1995006734A1 Cloning of a member of the serine-threonine-kinase family |
03/09/1995 | WO1995006733A2 Glycerin-3-phosphate-dehydrogenase (gpdh) |
03/09/1995 | WO1995006732A2 Bacterial exported proteins and acellular vaccines based thereon |
03/09/1995 | WO1995006731A2 Non-nucleotide containing enzymatic nucleic acid |
03/09/1995 | WO1995006730A1 Hybrid toxin |
03/09/1995 | WO1995006729A1 Differentially expressed leishmania genes and proteins |
03/09/1995 | WO1995006728A2 T cell epitopes of ryegrass pollen allergen |
03/09/1995 | WO1995006727A2 Uses of myelin oligodendrocyte glycoprotein and peptide portions thereof in protocols related to autoimmune disease |
03/09/1995 | WO1995006726A2 Dna molecule encoding for cellular uptake of mycobacterium tuberculosis |
03/09/1995 | WO1995006725A1 Immunoreactive peptide sequence from a 43 kd human cancer antigen |
03/09/1995 | WO1995006724A1 Vip2 (vasoactive intestinal polypeptide) receptor |
03/09/1995 | WO1995006723A1 Method of marking eukaryotic cells by the use of a cell surface receptor as a marker |
03/09/1995 | WO1995006722A1 Method of transforming monocotyledon by using scutellum of immature embryo |
03/09/1995 | WO1995006721A1 Gene serum opacity factor |
03/09/1995 | WO1995006718A2 Methods of suppressing autoimmune response |
03/09/1995 | WO1995006717A2 Methods of suppressing graft rejection |
03/09/1995 | WO1995006666A1 Anti-gp39 antibodies and uses therefor |
03/09/1995 | WO1995006664A1 Dna encoding prostaglandin receptor ep2 |
03/09/1995 | WO1995006662A1 Neuron regulatory factor for promoting neuron survival |
03/09/1995 | WO1995006661A1 MUTANTS OF THE Rb AND p53 GENES AND USES THEREOF |
03/09/1995 | WO1995006659A1 Amine-derivatized nucleosides and oligonucleosides |
03/09/1995 | WO1995006657A1 Interleukin-10 and immunosuppression |
03/09/1995 | WO1995006656A1 Neural tissue affecting factor and compositions |
03/09/1995 | WO1995006652A1 Nucleic acid purification compositions and methods |
03/09/1995 | WO1995006486A1 Treatment of human tumors by genetic transformation of human tumor cells |
03/09/1995 | WO1995006481A1 Methods for inducing antigen-specific t cell tolerance |
03/09/1995 | WO1995006478A1 RECOMBINANT COFFEE BEAN α-GALACTOSIDASE |
03/09/1995 | WO1995006474A1 Thiol-derivatized nucleosides and oligonucleosides |
03/09/1995 | WO1995006415A1 Senescent cell-derived inhibitors of dna synthesis |
03/09/1995 | WO1995002704A3 Poliovirus specific primers and methods of detection utilizing the same |
03/09/1995 | WO1995002691A3 Production and application of transgenic mushroom mycelium and fruitbodies |
03/09/1995 | WO1995002056A3 Lettuce infectious yellows virus genes |
03/09/1995 | WO1995001439A3 Plants having modified response to ethylene |
03/09/1995 | WO1994029457A3 Process for producing fusion proteins comprising scfv fragments by a transformed mould |
03/09/1995 | DE4419399C1 Process for the preparation of heterologous bispecific antibodies |
03/09/1995 | DE4329756A1 Process for the preparation and purification of alpha-interferon |
03/09/1995 | CA2565423A1 Enhanced expression in plants using non-translated leader sequences |
03/09/1995 | CA2170901A1 Uses of myelin oligodendrocyte glycoprotein and peptide portions thereof in protocols related to autoimmune disease |
03/09/1995 | CA2170899A1 Nucleic acid probes to mycobacterium avium complex |
03/09/1995 | CA2170882A1 Vector for gene therapy of the liver |
03/09/1995 | CA2170871A1 Oligonucleotides and methods for the detection of neisseria gonorrhoeae |
03/09/1995 | CA2170751A1 Neuron regulatory factor for promoting neuron survival |
03/09/1995 | CA2170726A1 Bacterial exported proteins and acellular vaccines based thereon |
03/09/1995 | CA2170725A1 Gene serum opacity factor |
03/09/1995 | CA2170611A1 Glycerin-3-phosphate-dehydrogenase (gpdh) |
03/09/1995 | CA2170393A1 Cloning of a member of the serine-threonine-kinase family |
03/09/1995 | CA2170390A1 Immunoreactive peptide sequence from a 43 kd human cancer antigen |
03/09/1995 | CA2170148A1 Dna molecule encoding for cellular uptake of mycobacterium tuberculosis |
03/09/1995 | CA2169951A1 Monoclonal antibody that recognizes interstitial cell surface antigen |